期刊
NATURE REVIEWS CANCER
卷 7, 期 5, 页码 327-331出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc2130
关键词
-
类别
Anti-angiogenesis therapies have emerged as important treatment options for several types of tumours. To date, these therapies have focused on blocking the vascular endothelial growth factor ( VEGF) pathway. A recent series of papers have shown that one ligand for the Notch receptors, Delta-like ligand 4 ( DLL4), is normally induced by VEGF and is a negative- feedback regulator that restrains vascular sprouting and branching. Consistent with this role, the deletion or inhibition of DLL4 results in excessive, non- productive angiogenesis. This unrestrained angiogenesis unexpectedly and paradoxically decreases tumour growth, even in tumours resistant to anti-VEGF therapies. Can too much angiogenesis be bad for tumours but good for patients?
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据